These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22004550)

  • 1. QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.
    Sridhar J; Foroozesh M; Stevens CL
    SAR QSAR Environ Res; 2011 Oct; 22(7-8):681-97. PubMed ID: 22004550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
    Jiang YR; Yang YY; Chen YL; Liang ZJ
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
    Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
    J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative QSAR studies using HQSAR, CoMFA, and CoMSIA methods on cyclic sulfone hydroxyethylamines as BACE1 inhibitors.
    Zhang S; Lin Z; Pu Y; Zhang Y; Zhang L; Zuo Z
    Comput Biol Chem; 2017 Apr; 67():38-47. PubMed ID: 28043074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative QSAR studies on peptide deformylase inhibitors.
    Lee JY; Doddareddy MR; Cho YS; Choo H; Koh HY; Kang JH; No KT; Pae AN
    J Mol Model; 2007 May; 13(5):543-58. PubMed ID: 17333308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
    Mondal C; Halder AK; Adhikari N; Jha T
    Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity.
    Garcia ML; de Oliveira AA; Bueno RV; Nogueira VHR; de Souza GE; Guido RVC
    Drug Dev Res; 2022 Apr; 83(2):264-284. PubMed ID: 32045013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
    Zhang S; Hou B; Yang H; Zuo Z
    Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.
    Korhonen LE; Rahnasto M; Mähönen NJ; Wittekindt C; Poso A; Juvonen RO; Raunio H
    J Med Chem; 2005 Jun; 48(11):3808-15. PubMed ID: 15916432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
    Gaurav A; Singh R
    Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
    Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
    J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies.
    Sharma MC; Jain S; Sharma R
    In Silico Pharmacol; 2017; 5():13. PubMed ID: 29098139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
    Dowlati Beirami A; Hajimahdi Z; Zarghi A
    J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
    Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
    Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of quantitative structure activity relationship methods based on antitumor diarylsulfonylureas.
    Park Choo HY; Lim JS; Kam Y; Kim SY; Lee J
    Eur J Med Chem; 2001 Oct; 36(10):829-36. PubMed ID: 11738489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico QSAR studies of anilinoquinolines as EGFR inhibitors.
    Pasha FA; Muddassar M; Srivastava AK; Cho SJ
    J Mol Model; 2010 Feb; 16(2):263-77. PubMed ID: 19590909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors.
    Castilho MS; Postigo MP; de Paula CB; Montanari CA; Oliva G; Andricopulo AD
    Bioorg Med Chem; 2006 Jan; 14(2):516-27. PubMed ID: 16203153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.